-
1
-
-
33644645358
-
Guidelines on the use and monitoring of heparin
-
Baglin, T., Barrowcliffe, T.W., Cohen, A. & Greaves, M. (2006) Guidelines on the use and monitoring of heparin. British Journal of Haematology, 133, 19-34.
-
(2006)
British Journal of Haematology
, vol.133
, pp. 19-34
-
-
Baglin, T.1
Barrowcliffe, T.W.2
Cohen, A.3
Greaves, M.4
-
2
-
-
0028039182
-
The effect of subcutaneous injection of unfractionated and low molecular weight heparin on thrombin generation in platelet rich plasma--a study in human volunteers
-
Bendetowicz, A.V., Kai, H., Knebel, R., Caplain, H., Hemker, H.C., Lindhout, T. & Beguin, S. (1994) The effect of subcutaneous injection of unfractionated and low molecular weight heparin on thrombin generation in platelet rich plasma--a study in human volunteers. Thrombosis and Haemostasis, 72, 705-712.
-
(1994)
Thrombosis and Haemostasis
, vol.72
, pp. 705-712
-
-
Bendetowicz, A.V.1
Kai, H.2
Knebel, R.3
Caplain, H.4
Hemker, H.C.5
Lindhout, T.6
Beguin, S.7
-
3
-
-
0038777381
-
Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability
-
Chantarangkul, V., Clerici, M., Bressi, C., Giesen, P.L. & Tripodi, A. (2003) Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. Haematologica, 88, 547-554.
-
(2003)
Haematologica
, vol.88
, pp. 547-554
-
-
Chantarangkul, V.1
Clerici, M.2
Bressi, C.3
Giesen, P.L.4
Tripodi, A.5
-
4
-
-
0027256792
-
Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery
-
Dahl, O.E., Pedersen, T., Kierulf, P., Westvik, A.B., Lund, P., Arnesen, H., Seljeflot, I., Abdelnoor, M. & Lyberg, T. (1993) Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thrombosis Research, 70, 451-458.
-
(1993)
Thrombosis Research
, vol.70
, pp. 451-458
-
-
Dahl, O.E.1
Pedersen, T.2
Kierulf, P.3
Westvik, A.B.4
Lund, P.5
Arnesen, H.6
Seljeflot, I.7
Abdelnoor, M.8
Lyberg, T.9
-
5
-
-
13244253700
-
Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time
-
Al Dieri, R., Alban, S., Beguin, S. & Hemker, H.C. (2004) Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time. Journal of Thrombosis and Haemostasis, 2, 1395-1401.
-
(2004)
Journal of Thrombosis and Haemostasis
, vol.2
, pp. 1395-1401
-
-
Al Dieri, R.1
Alban, S.2
Beguin, S.3
Hemker, H.C.4
-
6
-
-
33644848865
-
Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight
-
Al Dieri, R., Alban, S., Beguin, S. & Hemker, H.C. (2006) Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight. Journal of Thrombosis and Haemostasis, 4, 83-89.
-
(2006)
Journal of Thrombosis and Haemostasis
, vol.4
, pp. 83-89
-
-
Al Dieri, R.1
Alban, S.2
Beguin, S.3
Hemker, H.C.4
-
7
-
-
45949099359
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty
-
Eriksson, B.I., Borris, L.C., Friedman, R.J., Haas, S., Huisman, M.V., Kakkar, A.K., Bandel, T.J., Beckmann, H., Muehlhofer, E., Misselwitz, F. & Geerts, W. (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. The New England Journal of Medicine, 358, 2765-2775.
-
(2008)
The New England Journal of Medicine
, vol.358
, pp. 2765-2775
-
-
Eriksson, B.I.1
Borris, L.C.2
Friedman, R.J.3
Haas, S.4
Huisman, M.V.5
Kakkar, A.K.6
Bandel, T.J.7
Beckmann, H.8
Muehlhofer, E.9
Misselwitz, F.10
Geerts, W.11
-
8
-
-
46049090201
-
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
-
Geerts, W.H., Bergqvist, D., Pineo, G.F., Heit, J.A., Samama, C.M., Lassen, M.R. & Colwell, C.W. (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133, 381S-453S.
-
(2008)
Chest
, vol.133
-
-
Geerts, W.H.1
Bergqvist, D.2
Pineo, G.F.3
Heit, J.A.4
Samama, C.M.5
Lassen, M.R.6
Colwell, C.W.7
-
9
-
-
34247869897
-
Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation
-
Gerotziafas, G.T., Petropoulou, A.D., Verdy, E., Samama, M.M. & Elalamy, I. (2007a) Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation. Journal of Thrombosis and Haemostasis, 5, 955-962.
-
(2007)
Journal of Thrombosis and Haemostasis
, vol.5
, pp. 955-962
-
-
Gerotziafas, G.T.1
Petropoulou, A.D.2
Verdy, E.3
Samama, M.M.4
Elalamy, I.5
-
10
-
-
34147147085
-
In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban
-
Gerotziafas, G.T., Elalamy, I., Depasse, F., Perzborn, E. & Samama, M.M. (2007b) In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban. Journal of Thrombosis and Haemostasis, 5, 886-888.
-
(2007)
Journal of Thrombosis and Haemostasis
, vol.5
, pp. 886-888
-
-
Gerotziafas, G.T.1
Elalamy, I.2
Depasse, F.3
Perzborn, E.4
Samama, M.M.5
-
11
-
-
35448932027
-
Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity
-
Graff, J., Von, H.N., Misselwitz, F., Kubitza, D., Becka, M., Breddin, H.K. & Harder, S. (2007) Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity. Journal of Clinical Pharmacology, 47, 1398-1407.
-
(2007)
Journal of Clinical Pharmacology
, vol.47
, pp. 1398-1407
-
-
Graff, J.1
Von, H.N.2
Misselwitz, F.3
Kubitza, D.4
Becka, M.5
Breddin, H.K.6
Harder, S.7
-
12
-
-
0036145979
-
Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis
-
Greaves, M. (2002) Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thrombosis and Haemostasis, 87, 163-164.
-
(2002)
Thrombosis and Haemostasis
, vol.87
, pp. 163-164
-
-
Greaves, M.1
-
13
-
-
50249169222
-
Rivaroxaban: an oral direct inhibitor of factor Xa
-
Gulseth, M.P., Michaud, J. & Nutescu, E.A. (2008) Rivaroxaban: an oral direct inhibitor of factor Xa. American Journal of Health-System Pharmacy, 65, 1520-1529.
-
(2008)
American Journal of Health-System Pharmacy
, vol.65
, pp. 1520-1529
-
-
Gulseth, M.P.1
Michaud, J.2
Nutescu, E.A.3
-
14
-
-
0242401773
-
Calibrated automated thrombin generation measurement in clotting plasma
-
Hemker, H.C., Giesen, P., Al Dieri, R., Regnault, V., De Smedt, E., Wagenvoord, R., Lecompte, T. & Beguin, S. (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiology of Haemostasis and Thrombosis, 33, 4-15.
-
(2003)
Pathophysiology of Haemostasis and Thrombosis
, vol.33
, pp. 4-15
-
-
Hemker, H.C.1
Giesen, P.2
Al Dieri, R.3
Regnault, V.4
De Smedt, E.5
Wagenvoord, R.6
Lecompte, T.7
Beguin, S.8
-
15
-
-
33751210094
-
Thrombin generation, a function test of the haemostatic-thrombotic system
-
Hemker, H.C., Al Dieri, R., De Smedt, E. & Beguin, S. (2006) Thrombin generation, a function test of the haemostatic-thrombotic system. Thrombosis and Haemostasis, 96, 553-561.
-
(2006)
Thrombosis and Haemostasis
, vol.96
, pp. 553-561
-
-
Hemker, H.C.1
Al Dieri, R.2
De Smedt, E.3
Beguin, S.4
-
16
-
-
45949086068
-
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
-
Hirsh, J., Bauer, K.A., Donati, M.B., Gould, M., Samama, M.M. & Weitz, J.I. (2008) Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133, 141S-159S.
-
(2008)
Chest
, vol.133
-
-
Hirsh, J.1
Bauer, K.A.2
Donati, M.B.3
Gould, M.4
Samama, M.M.5
Weitz, J.I.6
-
17
-
-
0029040795
-
The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin
-
Hoppensteadt, D.A., Jeske, W., Fareed, J. & Bermes, Jr, E.W. (1995) The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin. Blood Coagulation & Fibrinolysis, 6(Suppl 1), S57-S64.
-
(1995)
Blood Coagulation & Fibrinolysis
, vol.6
, Issue.SUPPL. 1
-
-
Hoppensteadt, D.A.1
Jeske, W.2
Fareed, J.3
Bermes Jr, E.W.4
-
18
-
-
46049106502
-
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
-
Kakkar, A.K., Brenner, B., Dahl, O.E., Eriksson, B.I., Mouret, P., Muntz, J., Soglian, A.G., Pap, A.F., Misselwitz, F. & Haas, S. (2008) Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet, 372, 31-39.
-
(2008)
Lancet
, vol.372
, pp. 31-39
-
-
Kakkar, A.K.1
Brenner, B.2
Dahl, O.E.3
Eriksson, B.I.4
Mouret, P.5
Muntz, J.6
Soglian, A.G.7
Pap, A.F.8
Misselwitz, F.9
Haas, S.10
-
19
-
-
29144518504
-
Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects
-
Kubitza, D., Becka, M., Wensing, G., Voith, B. & Zuehlsdorf, M. (2005) Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects. European Journal of Clinical Pharmacology, 61, 873-880.
-
(2005)
European Journal of Clinical Pharmacology
, vol.61
, pp. 873-880
-
-
Kubitza, D.1
Becka, M.2
Wensing, G.3
Voith, B.4
Zuehlsdorf, M.5
-
20
-
-
45949103416
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty
-
Lassen, M.R., Ageno, W., Borris, L.C., Lieberman, J.R., Rosencher, N., Bandel, T.J., Misselwitz, F. & Turpie, A.G. (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. The New England Journal of Medicine, 358, 2776-2786.
-
(2008)
The New England Journal of Medicine
, vol.358
, pp. 2776-2786
-
-
Lassen, M.R.1
Ageno, W.2
Borris, L.C.3
Lieberman, J.R.4
Rosencher, N.5
Bandel, T.J.6
Misselwitz, F.7
Turpie, A.G.8
-
21
-
-
70449574622
-
Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
-
Laux, V., Perzborn, E., Heitmeier, S., Von, D.G., Dittrich-Wengenroth, E., Buchmuller, A., Gerdes, C. & Misselwitz, F. (2009) Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy? Thrombosis and Haemostasis, 102, 892-899.
-
(2009)
Thrombosis and Haemostasis
, vol.102
, pp. 892-899
-
-
Laux, V.1
Perzborn, E.2
Heitmeier, S.3
Von, D.G.4
Dittrich-Wengenroth, E.5
Buchmuller, A.6
Gerdes, C.7
Misselwitz, F.8
-
22
-
-
0027399508
-
Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhage
-
Leizorovicz, A., Bara, L., Samama, M.M. & Haugh, M.C. (1993) Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhage. Haemostasis, 23(Suppl 1), 89-98.
-
(1993)
Haemostasis
, vol.23
, Issue.SUPPL. 1
, pp. 89-98
-
-
Leizorovicz, A.1
Bara, L.2
Samama, M.M.3
Haugh, M.C.4
-
23
-
-
13244264708
-
Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition
-
Luddington, R. & Baglin, T. (2004) Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. Journal of Thrombosis and Haemostasis, 2, 1954-1959.
-
(2004)
Journal of Thrombosis and Haemostasis
, vol.2
, pp. 1954-1959
-
-
Luddington, R.1
Baglin, T.2
-
24
-
-
38149073315
-
Hemostasis factors and aging
-
Mari, D., Coppola, R. & Provenzano, R. (2008) Hemostasis factors and aging. Experimental Gerontology, 43, 66-73.
-
(2008)
Experimental Gerontology
, vol.43
, pp. 66-73
-
-
Mari, D.1
Coppola, R.2
Provenzano, R.3
-
25
-
-
78349293958
-
-
NICE. Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. Clinical guidance 92.
-
NICE. (2010) Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. Clinical guidance 92.
-
(2010)
-
-
-
26
-
-
22844442726
-
In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitor
-
Perzborn, E., Strassburger, J., Wilmen, A., Pohlmann, J., Roehrig, S., Schlemmer, K.H. & Straub, A. (2005) In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitor. Journal of Thrombosis and Haemostasis, 3, 514-521.
-
(2005)
Journal of Thrombosis and Haemostasis
, vol.3
, pp. 514-521
-
-
Perzborn, E.1
Strassburger, J.2
Wilmen, A.3
Pohlmann, J.4
Roehrig, S.5
Schlemmer, K.H.6
Straub, A.7
-
27
-
-
33646089867
-
The effect of different anticoagulants on thrombin generation
-
Petros, S., Siegemund, T., Siegemund, A. & Engelmann, L. (2006) The effect of different anticoagulants on thrombin generation. Blood Coagulation & Fibrinolysis, 17, 131-137.
-
(2006)
Blood Coagulation & Fibrinolysis
, vol.17
, pp. 131-137
-
-
Petros, S.1
Siegemund, T.2
Siegemund, A.3
Engelmann, L.4
-
28
-
-
0030603839
-
Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo
-
Planes, A., Vochelle, N., Darmon, J.Y., Fagola, M., Bellaud, M. & Huet, Y. (1996) Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet, 348, 224-228.
-
(1996)
Lancet
, vol.348
, pp. 224-228
-
-
Planes, A.1
Vochelle, N.2
Darmon, J.Y.3
Fagola, M.4
Bellaud, M.5
Huet, Y.6
-
29
-
-
77952044405
-
Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor
-
Samama, M.M., Martinoli, J.L., LeFlem, L., Guinet, C., Plu-Bureau, G., Depasse, F. & Perzborn, E. (2010) Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor. Thrombosis and Haemostasis, 103, 815-825.
-
(2010)
Thrombosis and Haemostasis
, vol.103
, pp. 815-825
-
-
Samama, M.M.1
Martinoli, J.L.2
LeFlem, L.3
Guinet, C.4
Plu-Bureau, G.5
Depasse, F.6
Perzborn, E.7
-
30
-
-
0023884505
-
Deep venous thrombosis: a continuing problem
-
Scurr, J.H., Coleridge-Smith, P.D. & Hasty, J.H. (1988) Deep venous thrombosis: a continuing problem. BMJ, 297, 28.
-
(1988)
BMJ
, vol.297
, pp. 28
-
-
Scurr, J.H.1
Coleridge-Smith, P.D.2
Hasty, J.H.3
-
31
-
-
0028810960
-
The John Charnley Award. Thrombogenesis during total hip arthroplasty
-
Sharrock, N.E., Go, G., Harpel, P.C., Ranawat, C.S., Sculco, T.P. & Salvati, E.A. (1995a) The John Charnley Award. Thrombogenesis during total hip arthroplasty. Clinical Orthopaedics and Related Research, 319, 16-27.
-
(1995)
Clinical Orthopaedics and Related Research
, vol.319
, pp. 16-27
-
-
Sharrock, N.E.1
Go, G.2
Harpel, P.C.3
Ranawat, C.S.4
Sculco, T.P.5
Salvati, E.A.6
-
32
-
-
0029028086
-
Changes in circulatory indices of thrombosis and fibrinolysis during total knee arthroplasty performed under tourniquet
-
Sharrock, N.E., Go, G., Sculco, T.P., Ranawat, C.S., Maynard, M.J. & Harpel, P.C. (1995b) Changes in circulatory indices of thrombosis and fibrinolysis during total knee arthroplasty performed under tourniquet. The Journal of Arthroplasty, 10, 523-528.
-
(1995)
The Journal of Arthroplasty
, vol.10
, pp. 523-528
-
-
Sharrock, N.E.1
Go, G.2
Sculco, T.P.3
Ranawat, C.S.4
Maynard, M.J.5
Harpel, P.C.6
-
33
-
-
65549169515
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
-
Turpie, A.G., Lassen, M.R., Davidson, B.L., Bauer, K.A., Gent, M., Kwong, L.M., Cushner, F.D., Lotke, P.A., Berkowitz, S.D., Bandel, T.J., Benson, A., Misselwitz, F. & Fisher, W.D. (2009) Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet, 373, 1673-1680.
-
(2009)
Lancet
, vol.373
, pp. 1673-1680
-
-
Turpie, A.G.1
Lassen, M.R.2
Davidson, B.L.3
Bauer, K.A.4
Gent, M.5
Kwong, L.M.6
Cushner, F.D.7
Lotke, P.A.8
Berkowitz, S.D.9
Bandel, T.J.10
Benson, A.11
Misselwitz, F.12
Fisher, W.D.13
-
34
-
-
41849145377
-
Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters
-
Van Veen, J.J., Gatt, A., Cooper, P.C., Kitchen, S., Bowyer, A.E. & Makris, M. (2008) Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters. Blood Coagulation & Fibrinolysis, 19, 183-189.
-
(2008)
Blood Coagulation & Fibrinolysis
, vol.19
, pp. 183-189
-
-
Van Veen, J.J.1
Gatt, A.2
Cooper, P.C.3
Kitchen, S.4
Bowyer, A.E.5
Makris, M.6
-
35
-
-
66449099711
-
Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans
-
Weinz, C., Schwarz, T., Kubitza, D., Mueck, W. & Lang, D. (2009) Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans. Drug Metabolism and Disposition, 37, 1056-1064.
-
(2009)
Drug Metabolism and Disposition
, vol.37
, pp. 1056-1064
-
-
Weinz, C.1
Schwarz, T.2
Kubitza, D.3
Mueck, W.4
Lang, D.5
-
36
-
-
0037394009
-
Low-molecular-weight heparins: are they all the same?
-
White, R.H. & Ginsberg, J.S. (2003) Low-molecular-weight heparins: are they all the same? British Journal of Haematology, 121, 12-20.
-
(2003)
British Journal of Haematology
, vol.121
, pp. 12-20
-
-
White, R.H.1
Ginsberg, J.S.2
|